PepGen Inc. (PEPG) - Latest Market Data

Price & Market Data

Price: $1.57

Daily Change: +$0.03 / 1.91%

Daily Range: $1.50 - $1.60

Market Cap: $104,445,512

Daily Volume: 569,611

Performance Metrics

1 Week: -6.03%

1 Month: -4.30%

3 Months: -76.18%

6 Months: -69.77%

1 Year: 10.63%

YTD: -75.91%

About PepGen Inc. (PEPG)

Full market details for PepGen Inc. (PEPG). Current price: 1.57, daily change: +$0.03 / 1.91%. Market cap: 104,445,512. Comprehensive performance data across all periods.

Company Details

Employees: 56

Sector: Health technology

Industry: Biotechnology

Country: United States

Details

PepGen Inc., a clinical-stage biotechnology company, develops oligonucleotide therapeutics for the treatment of severe neuromuscular and neurologic diseases in the United States. The company engages in the development of PGN-EDODM1, an EDO peptide-conjugated PMO, which is in Phase 2 clinical trial for the treatment of myotonic dystrophy type 1; and FREEDOM2-DM1, which is in Phase 2 for the treatment of myotonic dystrophy type 1. It is also involved in FREEDOM-OLE, an open label expansion study. The company was founded in 2018 and is based in Boston, Massachusetts.

Selected stocks

Universal Electronics Inc. (UEIC)

Tandy Leather Factory, Inc. (TLF)

Baiya International Group Inc. (BIYA)

Concorde International Group Ltd (YOOV)